Wang L, Liu L, Cao Y, Chen X, et al. Simultaneous integrated boost intensity-modulated radiotherapy (SIB-IMRT) combined with nimotuzumab for locally advanced esophageal squamous cell carcinoma (ESCC): A phase II clinical trial. BMC Cancer 2024;24:679.
PMID: 38831450